Akira Matsuno serves as President, CFO, and Co-Founder of Tune Therapeutics. His extensive biotech career includes co-founding and leadership roles at Lyell Immunopharma and Juno Therapeutics. He is also the co-founder of China-based CAR T company JW Therapeutics. His prior experience includes positions at Vulcan Capital (private equity) and Lehman Brothers (investment banking). Matsuno holds a B.S. in Finance and Management from the Wharton School.